Skip to main content
. 2022 Mar 28;14(7):1726. doi: 10.3390/cancers14071726

Figure 1.

Figure 1

Alternative splicing and cancer immunotherapy. Alternative splicing could have a direct impact on immunotherapy response by creating neoantigen peptide that could be recognized by immune cells. This is currently under investigation for the production of CAR-T cells.